Sanara MedTech Inc.

NASDAQ:SMTI

31.11 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200120001999
Revenue 64.9945.84324.14415.58711.7675.8386.3055.5083.3722.6331.7261.1742.210.910.2880.290.6310.190.2110.0850.0212.3052.251
Cost of Revenue 11.5286.3612.3111.6171.2090.5070.8060.9440.8920.8040.7930.7990.80.5381.1050.4170.2230.1930.2710.080.021.5131.422
Gross Profit 53.46239.48221.83313.9710.5575.335.4994.5642.481.8290.9340.3751.410.372-0.817-0.1270.407-0.003-0.060.0050.0010.7920.828
Gross Profit Ratio 0.8230.8610.9040.8960.8970.9130.8720.8290.7350.6950.5410.320.6380.409-2.837-0.4370.646-0.017-0.2850.0640.0480.3440.368
Reseach & Development Expenses 4.1323.3670.5590.040000000000000000000
General & Administrative Expenses 045.97628.05318.68413.0685.7365.2754.7653.3853.8353.813.2892.7462.9320.900000000
Selling & Marketing Expenses 00000000000000000000000
SG&A 56.99545.97628.05318.68413.0685.7365.2754.7653.3853.8353.813.2892.7462.9320.91.6320.8130.4850.6810.3071.3881.7481.601
Other Expenses 02.3710.5970.2910.12-0.022000.060.0560.2022.4770.4710.510.1250000.125.8280.0610.0580.065
Operating Expenses 61.12751.71429.20918.97513.1885.825.3564.8363.4453.8923.8625.7663.2173.4421.0251.6320.8130.4850.8016.1341.4491.8061.666
Operating Income -7.665-12.232-7.376-5.005-2.63-0.5020.12-0.272-0.965-2.063-2.928-5.418-5.015-3.07-1.842-1.759-0.406-0.488-0.741-6.129-1.448-1.014-0.702
Operating Income Ratio -0.118-0.267-0.306-0.321-0.224-0.0860.019-0.049-0.286-0.783-1.696-4.617-2.269-3.372-6.396-6.061-0.644-2.571-3.508-72.088-69.091-0.44-0.312
Total Other Income Expenses Net 3.225-1.705-0.6180.559-0.206-0.0250.3150.031-0.1990.0780.5063.666-10.95-1.421-0.46-0.014-0.137-0.1360.034-5.828-0.3-0.088-0.005
Income Before Tax -4.44-13.937-7.994-4.445-2.836-0.6010.331-0.416-1.34-2.278-4.148-1.845-12.741-5.135-2.303-1.773-0.543-0.624-0.758-6.137-1.748-1.102-0.98
Income Before Tax Ratio -0.068-0.304-0.331-0.285-0.241-0.1030.053-0.075-0.398-0.865-2.403-1.572-5.766-5.641-7.994-6.111-0.861-3.286-3.589-72.179-83.397-0.478-0.436
Income Tax Expense -0.137-5.845-0.688-0.0620.0940.013-0.315-0.0310.199-0.078-0.506-3.69310.951.460.460.0140.1370.136-0.1885.986-0.0740.072-0.496
Net Income -4.303-8.092-7.306-4.383-2.93-0.6010.331-0.416-1.34-2.278-4.148-1.845-12.741-5.135-2.303-1.773-0.543-0.624-0.758-6.295-1.53-1.1020.478
Net Income Ratio -0.066-0.177-0.303-0.281-0.249-0.1030.053-0.075-0.398-0.865-2.403-1.572-5.766-5.641-7.994-6.111-0.861-3.286-3.589-74.046-72.994-0.4780.212
EPS -0.52-1.02-1-0.76-1.37-0.280.17-0.38-1.26-2.16-4.84-2.68-21.69-14.34-7.92-8.08-3.36-3.86-4.84-68.92-2.15-1.59-0.7
EPS Diluted -0.52-1.02-1-0.76-1.37-0.280.092-0.38-1.25-2.16-4.84-2.68-21.69-14.34-7.92-8.08-3.36-3.86-4.84-68.92-2.15-1.59-0.7
EBITDA -3.99-10.241-7.396-4.698-2.5-0.4180.223-0.211-0.905-2.006-2.877-5.191-1.058-2.402-1.704-1.745-0.386-0.466-0.879-0.277-1.387-0.956-0.768
EBITDA Ratio -0.061-0.223-0.306-0.301-0.212-0.0720.035-0.038-0.268-0.762-1.666-4.423-0.479-2.639-5.918-6.013-0.612-2.456-4.163-3.256-66.175-0.415-0.341